CRESCENT BIOPHARMA, INC.
Company Stats
- Market Cap
- $541.9M
- as of Sep 30, 2026
- Shares Outstanding
- 37.1M
- Free Float
- 19.8%
Income Statement
- Revenue
- $10.8M
- Operating Income
- -$152.6M
- Net Income
- -$153.9M
- EBITDA
- -$152.5M
Cash Flow
- Free Cash Flow
- -$72.5M
- FCF Yield
- -13.4%
- Owner FCF Yield
- -15.8%
Balance Sheet
- Cash & Equivalents
- $213.2M
Returns & Capital
- Share Repurchases
- $177,000
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $10.8M | -$72.5M | -668.1% |
| FY2024 | — | -$31.1M | — |
| FY2023 | $10,000 | -$34.9M | -349013.0% |
| FY2022 | $75,000 | -$46.5M | -62055.6% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back